Trabeculectomy with mitomycin-C in neovascular galucoma patients

Ihsan Caça; Seyhmus Ari; Yildirim Bayezit Sakalar; Kaan Unlü; Eyüp Dogan

Trabeculectomy with mitomycin-C in neovascular galucoma patients

Ann Ophthalmol (Skokie). 2008 Summer;40(2):75-80.

Authors

Ihsan Caça¹, Seyhmus Ari, Yildirim Bayezit Sakalar, Kaan Unlü, Eyüp Dogan

Affiliation

¹ Department of Ophthalmology, Dicle University Faculty of Medicine, Diyarbakir, Turkey. ihsancaca@mynet.com

PMID: 19013913

Abstract

We sought to determine the effectiveness of trabeculectomy with mitomycin-C (MMC) in neovascular glaucoma (NVG) patients. Trabeculectomy with MMC in NVG patients is a method that has high rate of short-term success.

MeSH terms

Aged
Alkylating Agents / therapeutic use*
Combined Modality Therapy
Female
Glaucoma, Neovascular / drug therapy
Glaucoma, Neovascular / surgery
Glaucoma, Neovascular / therapy*
Humans
Intraocular Pressure
Male
Middle Aged
Mitomycin / therapeutic use*
Postoperative Complications
Trabeculectomy / methods*
Treatment Outcome

Substances

Alkylating Agents
Mitomycin